James Costello
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2024 | 259 | 2.660 |
Why?
| | Computational Biology | 12 | 2025 | 681 | 2.070 |
Why?
| | Cisplatin | 4 | 2024 | 334 | 1.510 |
Why?
| | Gene Expression Profiling | 11 | 2025 | 1786 | 1.400 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2024 | 883 | 1.390 |
Why?
| | Prostatic Neoplasms | 5 | 2025 | 978 | 1.260 |
Why?
| | Algorithms | 14 | 2025 | 1839 | 1.250 |
Why?
| | Down Syndrome | 4 | 2025 | 534 | 1.170 |
Why?
| | Systems Biology | 2 | 2025 | 72 | 1.080 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2197 | 1.060 |
Why?
| | Cell Line, Tumor | 23 | 2025 | 3550 | 0.960 |
Why?
| | Biomarkers, Tumor | 6 | 2025 | 1322 | 0.810 |
Why?
| | Transcriptome | 8 | 2024 | 1046 | 0.790 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 320 | 0.780 |
Why?
| | Rectal Neoplasms | 2 | 2023 | 158 | 0.760 |
Why?
| | Neoplasms | 10 | 2025 | 2884 | 0.750 |
Why?
| | Crowdsourcing | 5 | 2023 | 18 | 0.710 |
Why?
| | Software | 3 | 2025 | 692 | 0.700 |
Why?
| | Sarcoma | 1 | 2024 | 205 | 0.690 |
Why?
| | Computer Simulation | 5 | 2018 | 1026 | 0.690 |
Why?
| | Hot Temperature | 1 | 2024 | 407 | 0.670 |
Why?
| | Breast Neoplasms | 8 | 2025 | 2456 | 0.660 |
Why?
| | Premature Birth | 2 | 2023 | 380 | 0.660 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 33 | 0.660 |
Why?
| | Gene Expression Regulation, Neoplastic | 15 | 2025 | 1462 | 0.650 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 463 | 0.650 |
Why?
| | Cholangiocarcinoma | 3 | 2025 | 106 | 0.600 |
Why?
| | Blood Proteins | 1 | 2021 | 249 | 0.590 |
Why?
| | Bile Duct Neoplasms | 3 | 2025 | 128 | 0.590 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 13 | 0.580 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 205 | 0.570 |
Why?
| | Genomics | 7 | 2024 | 836 | 0.570 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 170 | 0.570 |
Why?
| | Chromosomes, Human | 1 | 2018 | 41 | 0.570 |
Why?
| | Fluorescence | 1 | 2018 | 161 | 0.550 |
Why?
| | Gestational Age | 1 | 2021 | 975 | 0.530 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 40 | 0.530 |
Why?
| | Humans | 75 | 2025 | 144957 | 0.530 |
Why?
| | Transcription Factors | 4 | 2022 | 1742 | 0.520 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 183 | 0.520 |
Why?
| | Genetic Loci | 1 | 2018 | 261 | 0.510 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 187 | 0.510 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 170 | 0.510 |
Why?
| | Models, Biological | 4 | 2018 | 1822 | 0.510 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 524 | 0.480 |
Why?
| | Body Mass Index | 1 | 2025 | 2438 | 0.470 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 193 | 0.470 |
Why?
| | Biomedical Research | 3 | 2025 | 710 | 0.460 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2025 | 292 | 0.460 |
Why?
| | Pancreatic Neoplasms | 4 | 2025 | 927 | 0.440 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1958 | 0.440 |
Why?
| | Telomerase | 4 | 2020 | 248 | 0.430 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 70 | 0.420 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 216 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 781 | 0.410 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2025 | 1141 | 0.390 |
Why?
| | Lung Neoplasms | 4 | 2025 | 2642 | 0.380 |
Why?
| | Competitive Behavior | 1 | 2013 | 43 | 0.380 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 758 | 0.370 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2025 | 42 | 0.370 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1500 | 0.360 |
Why?
| | Small Molecule Libraries | 2 | 2025 | 111 | 0.360 |
Why?
| | Receptors, Androgen | 3 | 2021 | 153 | 0.360 |
Why?
| | Animals | 34 | 2025 | 38109 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3869 | 0.350 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 68 | 0.340 |
Why?
| | Obesity | 1 | 2025 | 3082 | 0.340 |
Why?
| | Cooperative Behavior | 2 | 2016 | 465 | 0.330 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 64 | 0.320 |
Why?
| | Drosophila | 3 | 2008 | 166 | 0.320 |
Why?
| | Mutation | 8 | 2025 | 4099 | 0.320 |
Why?
| | Neoplasm Metastasis | 7 | 2025 | 695 | 0.310 |
Why?
| | Cadherins | 3 | 2024 | 201 | 0.310 |
Why?
| | Radiosurgery | 2 | 2024 | 401 | 0.310 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 105 | 0.290 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 311 | 0.280 |
Why?
| | Mice | 21 | 2025 | 18365 | 0.280 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 168 | 0.270 |
Why?
| | Aminopeptidases | 2 | 2024 | 21 | 0.270 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 236 | 0.260 |
Why?
| | Databases, Genetic | 3 | 2018 | 249 | 0.260 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 930 | 0.260 |
Why?
| | DNA Helicases | 2 | 2021 | 143 | 0.250 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 53 | 0.250 |
Why?
| | Adenocarcinoma | 2 | 2024 | 931 | 0.240 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2025 | 10 | 0.240 |
Why?
| | Signal Transduction | 8 | 2025 | 5233 | 0.230 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 211 | 0.220 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1258 | 0.220 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 39 | 0.220 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 116 | 0.220 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 174 | 0.220 |
Why?
| | Orthomyxoviridae Infections | 1 | 2025 | 72 | 0.220 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 220 | 0.210 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 685 | 0.210 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 12 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2738 | 0.210 |
Why?
| | Female | 26 | 2025 | 78376 | 0.200 |
Why?
| | Cell Proliferation | 9 | 2025 | 2499 | 0.200 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2025 | 132 | 0.200 |
Why?
| | Datasets as Topic | 1 | 2023 | 122 | 0.190 |
Why?
| | Rectum | 2 | 2023 | 180 | 0.190 |
Why?
| | Endometrial Neoplasms | 1 | 2025 | 208 | 0.190 |
Why?
| | Protein Biosynthesis | 1 | 2025 | 458 | 0.190 |
Why?
| | Neuroendocrine Tumors | 1 | 2024 | 114 | 0.190 |
Why?
| | Radiation Dosage | 1 | 2024 | 193 | 0.180 |
Why?
| | Proteomics | 3 | 2021 | 1195 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2020 | 749 | 0.180 |
Why?
| | Organoids | 1 | 2024 | 141 | 0.180 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 8 | 0.180 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 103 | 0.180 |
Why?
| | Melanoma | 2 | 2023 | 761 | 0.180 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2025 | 917 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 434 | 0.180 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 469 | 0.180 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 509 | 0.170 |
Why?
| | NF-kappa B | 1 | 2025 | 662 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 501 | 0.170 |
Why?
| | ROC Curve | 2 | 2021 | 615 | 0.170 |
Why?
| | Muscle Development | 1 | 2022 | 116 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 226 | 0.170 |
Why?
| | ADAM10 Protein | 1 | 2021 | 29 | 0.170 |
Why?
| | Gamma Rays | 1 | 2021 | 56 | 0.160 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 102 | 0.160 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 39 | 0.160 |
Why?
| | Gene Ontology | 1 | 2020 | 54 | 0.160 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 56 | 0.160 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 26 | 0.160 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 77 | 0.160 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 36 | 0.160 |
Why?
| | Machine Learning | 3 | 2025 | 587 | 0.160 |
Why?
| | Watchful Waiting | 1 | 2020 | 89 | 0.160 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 67 | 0.160 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 64 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 210 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2021 | 151 | 0.150 |
Why?
| | Receptors, Interferon | 1 | 2019 | 60 | 0.150 |
Why?
| | Homologous Recombination | 1 | 2019 | 36 | 0.150 |
Why?
| | RNA Interference | 1 | 2021 | 476 | 0.150 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 6 | 0.150 |
Why?
| | Cytokines | 2 | 2024 | 2065 | 0.150 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 735 | 0.150 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 421 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.140 |
Why?
| | Trisomy | 1 | 2019 | 78 | 0.140 |
Why?
| | Dasatinib | 1 | 2019 | 57 | 0.140 |
Why?
| | Cell Differentiation | 3 | 2022 | 2050 | 0.140 |
Why?
| | Immunotherapy | 2 | 2025 | 657 | 0.140 |
Why?
| | Chloroquine | 1 | 2018 | 53 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 548 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 67 | 0.140 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 444 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 128 | 0.140 |
Why?
| | Molecular Conformation | 1 | 2018 | 148 | 0.140 |
Why?
| | Prognosis | 7 | 2021 | 4293 | 0.140 |
Why?
| | Macrolides | 1 | 2018 | 69 | 0.140 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 173 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3415 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 428 | 0.140 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 457 | 0.140 |
Why?
| | Microbiota | 2 | 2023 | 781 | 0.140 |
Why?
| | Lysosomes | 1 | 2018 | 128 | 0.130 |
Why?
| | Monte Carlo Method | 1 | 2018 | 155 | 0.130 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 280 | 0.130 |
Why?
| | Histone Code | 1 | 2017 | 39 | 0.130 |
Why?
| | Probability | 1 | 2018 | 312 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2019 | 272 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 460 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 629 | 0.130 |
Why?
| | Cell Death | 1 | 2018 | 383 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 264 | 0.120 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 372 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | CD24 Antigen | 1 | 2016 | 18 | 0.120 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 25 | 0.120 |
Why?
| | DNA Damage | 1 | 2019 | 430 | 0.120 |
Why?
| | Organizational Innovation | 2 | 2016 | 120 | 0.120 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 31 | 0.120 |
Why?
| | Nomograms | 1 | 2016 | 59 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2018 | 383 | 0.120 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 241 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 581 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 162 | 0.110 |
Why?
| | Deoxycytidine | 1 | 2017 | 221 | 0.110 |
Why?
| | Male | 12 | 2025 | 72406 | 0.110 |
Why?
| | DNA Methylation | 2 | 2017 | 683 | 0.110 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 381 | 0.110 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 62 | 0.110 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.110 |
Why?
| | Up-Regulation | 1 | 2018 | 852 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 592 | 0.110 |
Why?
| | Bayes Theorem | 3 | 2023 | 433 | 0.110 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 33 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 412 | 0.110 |
Why?
| | Alleles | 1 | 2017 | 881 | 0.110 |
Why?
| | Histone Demethylases | 1 | 2014 | 38 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 668 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 56 | 0.110 |
Why?
| | Survival Rate | 4 | 2021 | 2092 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1167 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 586 | 0.100 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 68 | 0.100 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 5 | 0.100 |
Why?
| | Anabolic Agents | 1 | 2013 | 12 | 0.100 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1496 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2017 | 582 | 0.100 |
Why?
| | Drug Synergism | 1 | 2014 | 357 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 198 | 0.100 |
Why?
| | Phenotype | 2 | 2020 | 3164 | 0.100 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 157 | 0.100 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 38 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 906 | 0.100 |
Why?
| | Epigenomics | 1 | 2014 | 114 | 0.100 |
Why?
| | Databases, Protein | 2 | 2014 | 90 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2947 | 0.100 |
Why?
| | Phylogeny | 3 | 2023 | 1019 | 0.100 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 175 | 0.100 |
Why?
| | Neoplasm Staging | 3 | 2024 | 1465 | 0.100 |
Why?
| | Drug Combinations | 1 | 2014 | 392 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1169 | 0.100 |
Why?
| | Models, Molecular | 1 | 2018 | 1619 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2023 | 6434 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 683 | 0.090 |
Why?
| | Cluster Analysis | 2 | 2016 | 521 | 0.090 |
Why?
| | Superoxides | 1 | 2013 | 204 | 0.090 |
Why?
| | Prostate | 1 | 2013 | 158 | 0.090 |
Why?
| | Apoptosis | 3 | 2021 | 2430 | 0.090 |
Why?
| | Integrins | 2 | 2023 | 90 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 101 | 0.090 |
Why?
| | Models, Statistical | 1 | 2016 | 682 | 0.090 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 53 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 321 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4275 | 0.090 |
Why?
| | Lung | 1 | 2025 | 4109 | 0.090 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1322 | 0.090 |
Why?
| | Pregnancy | 2 | 2023 | 7191 | 0.090 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1407 | 0.090 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 253 | 0.090 |
Why?
| | Genome, Insect | 2 | 2009 | 28 | 0.080 |
Why?
| | B-Lymphocytes | 2 | 2014 | 877 | 0.080 |
Why?
| | Alternative Splicing | 1 | 2013 | 249 | 0.080 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 579 | 0.080 |
Why?
| | MCF-7 Cells | 2 | 2021 | 135 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 621 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2020 | 11695 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 826 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5997 | 0.080 |
Why?
| | Horns | 1 | 2009 | 1 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 328 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 420 | 0.080 |
Why?
| | Pseudogenes | 1 | 2009 | 20 | 0.080 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 43 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2365 | 0.080 |
Why?
| | Testosterone | 1 | 2013 | 419 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 36 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2025 | 2029 | 0.080 |
Why?
| | Coleoptera | 1 | 2009 | 29 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 536 | 0.070 |
Why?
| | Drug Discovery | 2 | 2022 | 155 | 0.070 |
Why?
| | Genes, Fungal | 1 | 2009 | 55 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2880 | 0.070 |
Why?
| | Stem Cells | 1 | 2013 | 627 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 919 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 389 | 0.070 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 44 | 0.070 |
Why?
| | Genes, Insect | 1 | 2007 | 22 | 0.070 |
Why?
| | Adult | 5 | 2025 | 40506 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1268 | 0.070 |
Why?
| | Disease | 1 | 2008 | 98 | 0.060 |
Why?
| | Zebrafish | 2 | 2022 | 528 | 0.060 |
Why?
| | BRCA1 Protein | 2 | 2020 | 81 | 0.060 |
Why?
| | Aged | 6 | 2025 | 25947 | 0.060 |
Why?
| | Genetics, Population | 1 | 2008 | 215 | 0.060 |
Why?
| | Genome, Human | 1 | 2009 | 422 | 0.060 |
Why?
| | Antigens, CD | 2 | 2024 | 555 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1129 | 0.060 |
Why?
| | Mitochondria | 1 | 2013 | 984 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2013 | 1339 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2008 | 256 | 0.060 |
Why?
| | Prednisone | 2 | 2017 | 221 | 0.060 |
Why?
| | Theranostic Nanomedicine | 1 | 2025 | 15 | 0.060 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2025 | 20 | 0.060 |
Why?
| | Maintenance Chemotherapy | 1 | 2025 | 42 | 0.060 |
Why?
| | Chromatin | 2 | 2022 | 561 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1982 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5417 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 120 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2025 | 247 | 0.050 |
Why?
| | Cell Line | 3 | 2019 | 2882 | 0.050 |
Why?
| | Base Sequence | 3 | 2017 | 2191 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2024 | 77 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 298 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 30 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2007 | 515 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 31 | 0.050 |
Why?
| | Cell Movement | 2 | 2021 | 965 | 0.050 |
Why?
| | BCG Vaccine | 1 | 2023 | 27 | 0.050 |
Why?
| | Chemokine CXCL9 | 1 | 2023 | 38 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 4155 | 0.050 |
Why?
| | Internet | 1 | 2008 | 700 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 688 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 128 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2276 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1915 | 0.050 |
Why?
| | Pituitary Neoplasms | 1 | 2024 | 190 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 15 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 405 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.040 |
Why?
| | MyoD Protein | 1 | 2022 | 31 | 0.040 |
Why?
| | Proteins | 1 | 2008 | 1022 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 96 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 154 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 245 | 0.040 |
Why?
| | Vagina | 1 | 2023 | 201 | 0.040 |
Why?
| | Cell Lineage | 2 | 2013 | 376 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1126 | 0.040 |
Why?
| | Chondrogenesis | 1 | 2022 | 88 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 488 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 780 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 109 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2022 | 133 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 126 | 0.040 |
Why?
| | Middle Aged | 5 | 2025 | 35928 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 45 | 0.040 |
Why?
| | Skull | 1 | 2022 | 158 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2022 | 3125 | 0.040 |
Why?
| | Precision Medicine | 1 | 2025 | 458 | 0.040 |
Why?
| | Breast | 1 | 2021 | 159 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 198 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 217 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 108 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 224 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 139 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 205 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 253 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 186 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 232 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 55 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8279 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 173 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 14 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 192 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 14126 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4569 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.030 |
Why?
| | Cell Cycle | 1 | 2021 | 597 | 0.030 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 25 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 56 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 966 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 442 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 165 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1721 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 610 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 82 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 970 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 36 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 116 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 151 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1253 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 124 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 144 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2119 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 257 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 183 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 6 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 510 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2147 | 0.030 |
Why?
| | Exome | 1 | 2016 | 227 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 197 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 33 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 824 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 313 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 56 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2931 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1385 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 252 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 33 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 13 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 8 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 381 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 309 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2609 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 243 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 727 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1187 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 43 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 224 | 0.020 |
Why?
| | Aminoglycosides | 1 | 2013 | 29 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 946 | 0.020 |
Why?
| | Area Under Curve | 1 | 2014 | 331 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2015 | 768 | 0.020 |
Why?
| | beta-Lactams | 1 | 2013 | 32 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1054 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 451 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 463 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 550 | 0.020 |
Why?
| | Genes, ras | 1 | 2012 | 96 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1054 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1486 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 294 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 99 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 854 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 336 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 190 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 437 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1464 | 0.020 |
Why?
| | Quinolones | 1 | 2013 | 201 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 498 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1371 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 14 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 978 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 126 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1098 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1718 | 0.020 |
Why?
| | Larva | 1 | 2009 | 242 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2185 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 14 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 27 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 460 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 855 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 29 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 22453 | 0.020 |
Why?
| | Codon | 1 | 2007 | 94 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2852 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 204 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 368 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 139 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 122 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2832 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10792 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7183 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 124 | 0.010 |
Why?
| | Reproduction | 1 | 2007 | 207 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2008 | 255 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2024 | 17101 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2007 | 212 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1796 | 0.010 |
Why?
| | Child | 1 | 2023 | 22657 | 0.010 |
Why?
| | RNA | 1 | 2008 | 940 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|